GOLDMAN SACHS GROUP INC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 93 filers reported holding CYTOKINETICS INC in Q1 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q2 2024$66,254,230
+29.9%
1,222,854
+68.1%
0.01%
+22.2%
Q1 2024$51,001,450
-40.0%
727,449
-28.5%
0.01%
-43.8%
Q4 2023$84,954,748
+306.5%
1,017,544
+43.4%
0.02%
+300.0%
Q3 2023$20,900,397
-42.1%
709,450
-35.9%
0.00%
-50.0%
Q2 2023$36,085,483
-4.6%
1,106,238
+3.0%
0.01%
-11.1%
Q1 2023$37,812,500
-9.3%
1,074,524
+18.0%
0.01%
-10.0%
Q4 2022$41,707,700
+126852.5%
910,251
+34.2%
0.01%
+25.0%
Q3 2022$32,853
+77.6%
678,084
+44.0%
0.01%
+60.0%
Q2 2022$18,496
-99.9%
470,753
-28.8%
0.01%0.0%
Q1 2022$24,347,000
-4.4%
661,446
+18.4%
0.01%0.0%
Q4 2021$25,466,000
-27.6%
558,704
-43.2%
0.01%
-28.6%
Q3 2021$35,184,000
+216.1%
984,465
+75.0%
0.01%
+250.0%
Q2 2021$11,132,000
-40.6%
562,503
-30.1%
0.00%
-60.0%
Q1 2021$18,731,000
+9.4%
805,288
-2.2%
0.01%
+25.0%
Q4 2020$17,118,000
-21.4%
823,764
-18.1%
0.00%
-42.9%
Q3 2020$21,782,000
+13.4%
1,006,131
+23.5%
0.01%
+16.7%
Q2 2020$19,201,000
+237.6%
814,639
+68.9%
0.01%
+200.0%
Q1 2020$5,687,000
+63.7%
482,349
+47.4%
0.00%
+100.0%
Q4 2019$3,473,000
+121.5%
327,302
+137.7%
0.00%
Q3 2019$1,568,000
+35.8%
137,704
+34.1%
0.00%
Q2 2019$1,155,000
-39.7%
102,672
-56.6%
0.00%
-100.0%
Q1 2019$1,916,000
+79.2%
236,829
+40.0%
0.00%
Q4 2018$1,069,000
-31.4%
169,187
+7.0%
0.00%
Q3 2018$1,558,000
-37.2%
158,159
-47.0%
0.00%
-100.0%
Q2 2018$2,479,000
-2.8%
298,651
-15.7%
0.00%0.0%
Q1 2018$2,551,000
-25.0%
354,263
-15.2%
0.00%0.0%
Q4 2017$3,403,000
-40.5%
417,597
+5.8%
0.00%0.0%
Q3 2017$5,721,000
+65.3%
394,566
+38.0%
0.00%0.0%
Q2 2017$3,461,000
+423.6%
286,018
+456.1%
0.00%
Q1 2017$661,000
-23.9%
51,430
-28.1%
0.00%
Q4 2016$869,000
-40.9%
71,491
-55.4%
0.00%
Q3 2016$1,470,000
+50.6%
160,162
+55.7%
0.00%
Q2 2016$976,000
+162.4%
102,839
+189.2%
0.00%
Q4 2015$372,000
+244.4%
35,554
+120.4%
0.00%
Q3 2015$108,000
-89.8%
16,134
-89.7%
0.00%
Q2 2015$1,055,000
+0.8%
157,035
+1.7%
0.00%
Q1 2015$1,047,000
-53.1%
154,340
-44.6%
0.00%
Q4 2014$2,232,000
+717.6%
278,652
+259.7%
0.00%
Q3 2014$273,000
+7.1%
77,470
+45.6%
0.00%
Q2 2014$255,000
-96.0%
53,197
-92.0%
0.00%
-100.0%
Q1 2014$6,327,000
+7808.8%
666,027
+6193.4%
0.00%
Q3 2013$80,00010,5830.00%
Other shareholders
CYTOKINETICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
BVF INC/IL 5,721,888$46,633,0005.62%
IRONWOOD INVESTMENT MANAGEMENT LLC 107,139$873,0000.62%
Virtus ETF Advisers LLC 42,645$348,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 210,000$1,712,0000.20%
LANSDOWNE PARTNERS (UK) LLP 2,647,981$21,581,0000.20%
WASATCH ADVISORS LP 1,679,778$13,690,0000.18%
PINNACLE ASSOCIATES LTD 877,575$7,152,0000.14%
ESSEX INVESTMENT MANAGEMENT CO LLC 107,728$878,0000.12%
Tekla Capital Management LLC 350,300$2,855,0000.11%
Financial Gravity Companies, Inc. 9,302$86,0000.10%
View complete list of CYTOKINETICS INC shareholders